{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibnokg7ctlk3i523vrikijoti4h5xt7x43zdpzvjssnjha6snwrv4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mmxfmtfplv62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/28/hepatitis-drug-cvs-returns-lilly-obesity-drug-to-formularies/?utm_campaign=rss",
  "publishedAt": "2026-05-28T13:26:16.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.",
  "title": "STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more",
  "updatedAt": "2026-05-28T13:26:22.000Z"
}